Video
Mark Zitter, CEO at Zitter Health Insights, explains how the growth of Accountable Care Organizations may impact specialty drug management in the near future.
Mark Zitter, CEO at Zitter Health Insights, explains how the growth of Accountable Care Organizations may impact specialty drug management in the near future.
For more videos from industry experts, visit our Multimedia page.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa